Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Lyle Feinstein"'
Publikováno v:
Neurol Clin Pract
Although a rare occurrence, EBV-positive primary CNS lymphoma may occur anywhere in the CNS as well as in immunocompetent patients.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ada10cce785a5d46af9de3bce9062681
https://europepmc.org/articles/PMC6927448/
https://europepmc.org/articles/PMC6927448/
Autor:
Judith Luck, Yves Pangilinan, Kristin Levoy, Maria Lopez-Bover, Lyle Feinstein, Mary Mackrell, Ana Leyva
Publikováno v:
Biology of Blood and Marrow Transplantation. 21(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a96ae162e8be7daaacd96aefb28d4cf
Autor:
Thomas R. Chauncey, David G. Maloney, Jerry P. Radich, Brenda M. Sandmaier, George E. Georges, Jan M. Zaucha, A. Woolfrey, Judith A. Shizuru, Peter A. McSweeney, Richard A. Nash, Dietger Niederwieser, Marie Térèse Little, Hans-Peter Kiem, Karl G. Blume, Christopher R. Flowers, Rainer Storb, Lyle Feinstein, Michael B. Maris
Publikováno v:
Annals of the New York Academy of Sciences. 938:328-339
Conventional allografting produces considerable regimen-related toxicities that generally limit this treatment to patients younger than 55 years and in otherwise good medical condition. T cell-mediated graft-versus-tumor (GVT) effects are known to pl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::465e8241c0df5be470b2e1fb3a2acd85
https://doi.org/10.1111/j.1749-6632.2001.tb03601.x
https://doi.org/10.1111/j.1749-6632.2001.tb03601.x
Autor:
Frederick R. Appelbaum, Dietger Niederwieser, Ted Gooley, Peter A. McSweeney, Brenda M. Sandmaier, Thomas R. Chauncey, Michael B. Maris, U Hegenbart, Benedetto Bruno, David G. Maloney, Lyle Feinstein, Rainer Storb
Publikováno v:
British Journal of Haematology. 120:281-288
Summary. Many patients with acute myeloid leukaemia (AML) in first complete remission (CR1) are ineligible for allogeneic transplantation as a result of age or medical problems other than leukaemia. Eighteen patients (median age 59 years, range 36–
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7bedac7bd5924199635071021ce55e21
https://doi.org/10.1046/j.1365-2141.2003.04057.x
https://doi.org/10.1046/j.1365-2141.2003.04057.x
Autor:
Stephen J. Forman, Peter A. McSweeney, Michael B. Maris, Rainer Storb, David G. Maloney, Ann Woolfrey, Lyle Feinstein, Dietger Niederwieser, Thomas Chauncey, Beverly Torok-Storb, Marco Mielcarek, Karl G. Blume, Brenda M. Sandmaier
Publikováno v:
Journal of Clinical Immunology. 22:70-74
In nonmyeloablative allogeneic hematopoietic stem cell transplantation (HSCT), high-dose cytotoxic therapy as the conceptual basis for treating hematopoietic malignancies has been replaced by graft-versus-tumor effects. The use of potent pre- and pos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::31780ae2741c1e3d7cc92a6976413d13
https://doi.org/10.1023/a:1014532401666
https://doi.org/10.1023/a:1014532401666
Autor:
Paul J. Martin, Jan Storek, Raleigh A. Bowden, Frederick R. Applebaum, Kristy Seidel, John A. Hansen, Mary E.D. Flowers, Rainer Storb, Ruth Etzioni, Emin Kansu, H. Joachim Deeg, Claudio Anasetti, Lyle Feinstein, Richard A. Nash, Jane Jocum, Keith M. Sullivan
Publikováno v:
Biology of Blood and Marrow Transplantation. 5(6):369-378
Graft-vs.-host disease (GVHD) and infection are major complications of allogeneic bone marrow transplantation. Intravenous immunoglobulin (IVIg) given at a dose of 500 mg/kg/wk has been shown to decrease the risk of acute GVHD, interstitial pneumonia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6794bc3ebf3997dc9f168d0f3de2787c
Autor:
Monic J. Stuart, Karl G. Blume, Michael B. Maris, Stephen J. Forman, Brenda M. Sandmaier, Dietger Niederwieser, Peter A. McSweeney, Thomas R. Chauncey, David G. Maloney, U Hegenbart, Michael A. Pulsipher, Edward Agura, Lyle Feinstein, Rainer Storb, Ted Gooley
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 9(4)
Outcomes with conventional allogeneic hematopoietic cell transplantation (HCT) after failed HCT are typically poor. To reduce transplantation-related mortality (TRM), 55 patients (median age, 43 years; range, 18-69 years) who had failed conventional
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72fcc58eb00b6882986fb5c5b532b70e
https://pubmed.ncbi.nlm.nih.gov/12720219
https://pubmed.ncbi.nlm.nih.gov/12720219
Autor:
B. M. Sandmaier, Ann E. Woolfrey, Lyle Feinstein, M. Maris, Richard A. Nash, Peter A. McSweeney, David G. Maloney, Dietger Niederwieser, Th. Chauncey, George E. Georges, Rainer Storb, Blume Kg, J. Maciej Zaucha, J. Shizuru
Publikováno v:
Haematology and Blood Transfusion Hämatologie und Bluttransfusion ISBN: 9783642639494
The development of nonmyeloablative allogeneic hematopoietic stem cell transplantation (HSCT) from the preclinical studies to the clinic has permitted the treatment of a larger number of patients who previously had not been candidates for the standar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::06b6890f2ff638ecf83684bcdd8ddaa6
https://doi.org/10.1007/978-3-642-59358-1_80
https://doi.org/10.1007/978-3-642-59358-1_80
Autor:
Judith A. Shizuru, David G. Malone, Stephen J. Forman, Marie Trse Little, Peter A. McSweeney, Brenda M. Sandmaier, Michael B. Maris, Michael A. Pulsipher, Benedetto Bruno, Thomas R. Chauncey, Lyle Feinstein, George E. Georges, U Hegenbart, Ann E. Woolfrey, Firoozeh Sahebi, Edward Agura, Rainer Storb, Jerald P. Radich, Dietger Niederweiser, Karl G. Blume
Publikováno v:
International journal of hematology. 76
Patients with advanced hematological malignancies ineligible for conventional myeloablative allogeneic hematopoietic stem cell transplantation (HSCT) due to advanced age or medical contraindications were enrolled in multi-center study to investigate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5c856adf6cecaa1486e3b413e89efae
https://pubmed.ncbi.nlm.nih.gov/12430851
https://pubmed.ncbi.nlm.nih.gov/12430851
Autor:
Marco, Mielcarek, Brenda M, Sandmaier, David G, Maloney, Michael, Maris, Peter A, McSweeney, Ann, Woolfrey, Thomas, Chauncey, Lyle, Feinstein, Dietger, Niederwieser, Karl G, Blume, Stephen, Forman, Beverly, Torok-Storb, Rainer, Storb
Publikováno v:
Journal of clinical immunology. 22(2)
In nonmyeloablative allogeneic hematopoietic stem cell transplantation (HSCT), high-dose cytotoxic therapy as the conceptual basis for treating hematopoietic malignancies has been replaced by graft-versus-tumor effects. The use of potent pre- and pos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::299e5de1753ac3910bd17c9902ec6b2e
https://pubmed.ncbi.nlm.nih.gov/11998895
https://pubmed.ncbi.nlm.nih.gov/11998895